Mass General Brigham, Inc

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 5, 2026), Mass General Brigham, Inc reported 6 stock positions worth $468.9 million. Its top holding was iShares MSCI Acwi ETF (ACWI) at 62.4% of the portfolio, followed by Karman (KRMN, 26.7%) and Revolution Medicines (RVMD, 7.1%). Compared with Q4 2025, it sold out of 1, added to 1 and reduced 1. The biggest buy was Medline Class A (MDLN, shares +168%) and the biggest sale iShares MSCI Acwi ETF (ACWI, shares −53%).

Most Recent 13F
Q2 2026
Location
SOMERVILLE, MA
CIK
0001678378
Portfolio Value
$468.9M (Q1 2026)
SEC Filing
0001214659-26-005558 ↗ filed May 5, 2026

Holdings Value

0$200.0M$400.0M$600.0M$800.0M$1.0B Q1 2024: $57.1M Q1 2024 Q2 2024: $20.5M Q2 2024 Q3 2024: $43.6M Q3 2024 Q4 2025: $809.8M Q4 2025 Q1 2026: $468.9M $468.9M Q1 2026 Q2 2026: $361.1M Q2 2026

Holdings 6 stocks · $468.9M

ACWI iShares MSCI Acwi ETF 62.42% 2,153,477 $292.7M Reduce -53.3%
KRMN Karman Holdings Inc. 26.67% 1,562,054 $125.0M No change
RVMD Revolution Medicines Inc. 7.14% 344,091 $33.5M No change
TNGX Tango Therapeutics Inc. 1.58% 354,192 $7.4M No change
MAZE Maze Therapeutics Inc. 1.53% 239,994 $7.2M No change
MDLN Medline Inc. Class A 0.67% 70,357 $3.1M Add +167.6%

Portfolio Sells Q4 2025 → Q1 2026

ACWI iShares MSCI Acwi ETF Reduce -53.3% 62.42% −18.20
RBRK Rubrik Inc. Class A Sold out 0.00% −0.13

Portfolio Buys Q4 2025 → Q1 2026

MDLN Medline Inc. Class A Add +167.6% 0.67% +0.53

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 6$361.1MACWI, KRMN, RVMD, TNGX, MAZE
Q1 2026 6$468.9MACWI, KRMN, RVMD, TNGX, MAZE
Q4 2025 7$809.8MACWI, KRMN, RVMD, MAZE, TNGX
Q3 2024 5$43.6MIOT, RVMD, PLRX, TNGX, FULC
Q2 2024 4$20.5MRVMD, PLRX, TNGX, FULC
Q1 2024 5$57.1MCOIN, RVMD, PLRX, TNGX, FULC